Which are the causes of STXBP1?

STXBP1 is a rare neurodevelopmental disorder caused by a pathogenic variant (mutation) in the STXBP1 gene, which is essential for the proper communication between neurons in the brain. This genetic mutation disrupts the release of neurotransmitters, leading to the seizures, developmental delays, and intellectual disabilities characteristic of STXBP1-related disorders.

What causes STXBP1-related disorders?

The primary cause of STXBP1 is a genetic mutation that prevents the STXBP1 protein from functioning correctly. Think of this protein as a "gatekeeper" that helps synaptic vesicles release chemical messengers between brain cells. When the STXBP1 gene is mutated, the gatekeeper fails, and the brain struggles to send signals, resulting in impaired neurological function.

Is STXBP1 an inherited condition?

In the vast majority of cases, STXBP1 is not inherited from parents. Instead, it occurs as a de novo (new) mutation in the affected individual. This means the genetic change happens spontaneously during the formation of the egg or sperm, or very early in embryonic development. Because it is usually a new occurrence, parents of a child with STXBP1 typically have a very low risk of having another child with the same condition.

What are the specific genetic mechanisms?

The molecular disruption in STXBP1 is characterized by several types of genetic changes, including:

• Missense mutations: A single "letter" change in the DNA code that alters the protein structure.


• Nonsense mutations: A change that creates a premature "stop" signal, leading to an incomplete and non-functional protein.


• Deletions: The loss of part or all of the STXBP1 gene, preventing any protein production.


• Frameshift mutations: An insertion or deletion that shifts the reading frame of the gene, resulting in a garbled genetic instruction.

Is the etiology of STXBP1 fully understood?

While we know that a mutation in the STXBP1 gene is the definitive cause, researchers are still actively studying how different types of mutations lead to the wide spectrum of clinical severity seen in the 271 patients currently in the DiseaseMaps community. Current research is focused on how these genetic deficits specifically impact synaptic plasticity and whether gene-therapy approaches can one day restore protein function.

Next steps

• Consult a clinical geneticist to confirm your specific STXBP1 variant through diagnostic testing.


• Connect with the DiseaseMaps.org community to share experiences and learn from other families managing STXBP1.


• Review the latest clinical trials and research updates via the STXBP1 Foundation.

Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment.

References

• NIH Genetic and Rare Diseases Information Center (GARD): STXBP1-related disorders.


• Online Mendelian Inheritance in Man (OMIM): Entry #602926 (STXBP1).


• Orphanet: Rare disease database entry for STXBP1 encephalopathy.


• The STXBP1 Foundation: Clinical research and patient resources.